This study assessed the prophylactic bethanechol use to prevent salivary gland dysfunction during radiotherapy. A total of 97 head and neck cancer patients were allocated into two groups: Bethanechol or Placebo. Bethanechol group presented significantly improve of salivary parameters. Bethanechol was effective in decreasing the salivary gland damage.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.radonc.2015.03.017 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!